Geneva Network Contribution to the EC’s Pharmaceutical Strategy Roadmap

September 16, 2020

This letter briefly elaborates four areas we believe the Roadmap should focus on in order to retain Europe’s competitiveness and ensure health-related innovation meets the future needs of Europe’s population:

 

  • Maintain high standards of IP protection to promote economic growth and protect the EU’s global competitiveness
  • Strengthen the EU’s innovation ecosystem by ensuring all publicly-funded research institutions can license and profit from their research
  • Reform the patent system to strengthen R&D incentives for the diseases of aging and other unmet needs
  • Ensure GDPR does not present a barrier to data-driven drug development in the EU.